known as type 3 innate lymphoid cells (ILC3), are present in significantly higher numbers in the duodenum of FAP patients. "We found an increased number of these cells in the mucosa, particularly ...

"Targeting these immune cells or, in particular, blocking the messenger substance IL-17A directly in the duodenum could therefore represent a promising new approach to preventing duodenal cancer ...